today EAO Lisbon 26 September 2019

EAO 2019 builds bridges to future of implantology / News / Floor plan / List of exhibitors / Industry / Travel

Open PDF View E-paper Edit Epaper Edit Epaper ads save

Table of contents

) [16] => Array ( [image_url] => Array ( [2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77892-481f0d5a/2000/page-15.jpg [1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77892-481f0d5a/1000/page-15.jpg [200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77892-481f0d5a/200/page-15.jpg ) [key] => Array ( [2000] => 77892-481f0d5a/2000/page-15.jpg [1000] => 77892-481f0d5a/1000/page-15.jpg [200] => 77892-481f0d5a/200/page-15.jpg ) [ads] => Array ( [0] => Array ( [post_data] => WP_Post Object ( [ID] => 77899 [post_author] => 0 [post_date] => 2024-10-23 20:19:46 [post_date_gmt] => 2024-10-23 20:19:46 [post_content] => [post_title] => epaper-77892-page-16-ad-77899 [post_excerpt] => [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => epaper-77892-page-16-ad-77899 [to_ping] => [pinged] => [post_modified] => 2024-10-23 20:19:46 [post_modified_gmt] => 2024-10-23 20:19:46 [post_content_filtered] => [post_parent] => 0 [guid] => https://e.dental-tribune.com/ad/epaper-77892-page-16-ad/ [menu_order] => 0 [post_type] => ad [post_mime_type] => [comment_count] => 0 [filter] => raw ) [id] => 77899 [id_hash] => 2a8acfa3d5ceaf01599c41ffd01edb921d4e7fea3107311b3f9ab9681edd1313 [post_type] => ad [post_date] => 2024-10-23 20:19:46 [fields] => Array ( [url] => https://www.dental-tribune.com/c/nobel-biocare-services-ag/ [link] => URL ) [permalink] => https://e.dental-tribune.com/ad/epaper-77892-page-16-ad-77899/ [post_title] => epaper-77892-page-16-ad-77899 [post_status] => publish [position] => 1.423487544484,0.74812967581047,98.220640569395,99.002493765586 [belongs_to_epaper] => 77892 [page] => 16 [cached] => false ) ) [html_content] =>

Open Link

) ) [pdf_filetime] => 1729714785 [s3_key] => 77892-481f0d5a [pdf] => today EAO Lisbon Sep.26, 2019.pdf [pdf_location_url] => https://e.dental-tribune.com/tmp/dental-tribune-com/77892/today EAO Lisbon Sep.26, 2019.pdf [pdf_location_local] => /var/www/vhosts/e.dental-tribune.com/httpdocs/tmp/dental-tribune-com/77892/today EAO Lisbon Sep.26, 2019.pdf [should_regen_pages] => 1 [pdf_url] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/77892-481f0d5a/epaper.pdf [pages_text] => Array ( [1] => TDI0819_01-16.pdf

25
26
27

EAO 28th Annual Scientiﬁc Meeting Lisbon · 26–28 September 2019

Interview

Implantology news

Interview

In preparation for EAO 2019, DTI spoke with
congress chair Dr Gil Alcoforado about what
is in store for those making the trip to Lisbon.

Learn about novel techniques, the latest developments, recent studies, and more in implant dentistry.

» page 2

Prof. Neil Meredith, co-inventor of resonance
frequency analysis and co-founder of Osstell,
gives details about the company’s upcoming
symposium.
» page 12

EAO 2019 builds bridges to future of implantology
28th Annual Scientiﬁc Meeting taking place in Lisbon.
© CCL

From 26 to 28 September, the Lisbon Congress Centre will play host to
the 28th Annual Scientiﬁc Meeting of
the European Association for Osseointegration (EAO). The congress
promises to deliver an engaging
learning atmosphere for attendees
through a mix of lectures, hands-on
workshops and clinical video sessions.
Under the theme “The bridge to
the future”, the 2019 EAO congress is
set to shine a spotlight on the future
directions of implant dentistry. The
scientiﬁc programme reﬂects this
theme, according to the event’s organising committee, by providing dynamic and interactive sessions in
which internationally prominent
speakers will be discussing topics at
the cutting edge of research and innovation.
“Attendees will have a great
choice of different sessions with
plenty of renowned speakers from all
© Mapics/Shutterstock.com

over the world,” said Prof. Gil Alcoforado, Chair of the 2019 EAO congress.
“The scientiﬁc programme was built
around questions that many clinicians ask themselves when treating
patients.”
“Several bridges will be crossed:
from analogue to digital, from surgical to microsurgical, and from the
staged implant protocol to the immediate placement and loading of implants,” Alcoforado continued.
In keeping with this forwardthinking theme, this year’s congress
will see the debut of a dedicated
EAO channel on YouTube. This will
make available all the main sessions
and debates, allowing for attendees
to review the event’s scientiﬁc content.
Also being featured for the ﬁrst
time this year will be a competition
for the best cell biology photograph.
A jury, consisting of the EAO’s Drs
Kathrin Becker and Björn Klinge, will

determine which of the submitted implant dentistry-related photographs
is worthy of adorning the cover of an
upcoming issue of Clinical Oral Implants Research, the EAO’s ofﬁcial
publication.
A clinical video competition will
also be held at Lisbon and the best
will be presented during a dedicated
session on the ﬁrst afternoon of the
congress. The winner will receive the
European Prize for Clinical Video on
Implant Dentistry, as well as a cash
prize of €2,000, and his or her video
will be broadcast on the EAO’s social
media channels.
At this year’s congress, Brazil will
be featured as the guest country. Brazil currently has the highest number
of EAO members of any South American country, and its mutual history
with Portugal makes it a natural
choice for this year, according to the
EAO. A dedicated Brazil and friends
session on the topic of “Improved aes-

thetic outcomes with anterior implants” will be held on the afternoon
of 27 September.
Attendees will additionally be
able to learn about the latest innovations from the 120 companies present.
Ten satellite industry symposia, sponsored by Nobel Biocare, Straumann

and Dentsply Sirona, among others,
will also highlight the newest clinical
solutions that are available.
Since its foundation in Munich in
Germany in 1991, the EAO has grown
to become one of the leading associations within the discipline of osseointegration. The EAO was created as an
international and independent exchange forum for dentists interested
in the science of implant dentistry.
The ﬁrst congress was held in Leuven
in Belgium in 1992 for fewer than
500 attendees; the 28th instalment is
expecting upwards of 3,500.
Though the ofﬁcial language of
the EAO congress is English, some
sessions will be interpreted into Portuguese.
Further information about the
scientiﬁc meeting and programme of
the 2019 EAO congress is available
on the organisation’s website and
through the EAO Congress 2019
app.
AD

EVENTS

SERVICES
EDUCATION

DIGITAL

Dental Tribune International

The World's
Dental Marketplace
www.dental-tribune.com

[2] => TDI0819_01-16.pdf

news

“Attendees will have a great choice of different sessions”
An interview with Dr Gil Alcoforado, 2019 EAO congress chair, by Brendan Day, DTI.
Though the 28th Annual Scientiﬁc
Meeting of the EAO will last for just
three days, planning and preparation
for the meeting dates back to more
than a year and a half ago, according
to Dr Gil Alcoforado, this year’s congress chair. Dental Tribune International spoke with him about his involvement with the EAO, the amount
of work that went into organising this
year’s congress, and what is in store
for those making the trip to Lisbon.
Dr Alcoforado, could you please provide a little background on your history with the EAO?
I have been a member of the EAO
for many years because I’ve always
thought it is the association which
best represents implant dentistry—
not just in Europe but worldwide as
well. A few months after I ﬁnished
my commitment of many years as a
member of the board of the European
Federation of Periodontology, I was
invited by several EAO board members to stand for election, and in
October 2016, I became a member of
the EAO board.
I very quickly realised the potential for growth in this organisation.
The fantastic atmosphere and friendliness that I have encountered in
serving on the board has motivated
me to better serve our members. After a brainstorming session—something we do annually—the idea arose
to create a series of master clinician
courses. It was the ﬁrst and biggest
assignment that I carried out by myself as an EAO board member. For
several years, I created and organised the ﬁrst ten master clinician
courses, which proved to be extremely successful. Later on, I ﬁlled
the vacancy of the Chair of the EAO
Education Committee—a role that I
still occupy.

What was the timeline for organising
this year’s congress like? When did
preparations for the scientiﬁc programme begin?
When the board decided on Lisbon as the venue for this year’s congress, I had to start preparing the sci-

3,500 participants, which is an excellent number. I sincerely hope that attendees will enjoy the presentations,
the city of Lisbon and the social part of
the programme, where they will have
a great opportunity to meet up with
many of their friends and colleagues.

questions that many clinicians ask
themselves when treating patients.
Some of the answers to these questions, to be fair, are not yet in the domain of evidence-based dentistry.
However, owing to the development
of clinical procedures, these problems exist and clinicians want to
know how to solve them. Some of the
sessions will thus highlight a means
of addressing a number of these problems and will have different experts
demonstrating how they themselves
manage these difﬁcult clinical situations.
The theme of this year’s congress is
“The bridge to the future”—the future of implant dentistry, that is. How
does the scientiﬁc programme reﬂect this theme?
Broadly speaking, several bridges
will be crossed: from analogue to digital, from surgical to microsurgical,
and from the staged implant protocol
to the immediate placement and loading of implants. These are just some
of the areas in which bridges will be
crossed by both speakers, as well as
attendees.

entiﬁc programme immediately. To
do so, I enlisted the help of all the
members of the EAO Scientiﬁc Committee. After one and a half years of
hard work and careful deliberation,
the preliminary programme was presented to the EAO board and eventually approved. Our choice of speakers
was based on speciﬁc criteria: for example, the speakers were required to
put forward topics relevant to our
conception of implant dentistry.
Judging by the current statistics, it
seems we will have around 3,200 to

What can attendees expect from this
year’s EAO congress?
Attendees will have a great
choice of different sessions with
plenty of renowned speakers from all
over the world scheduled to present.
They will see the latest innovations in
implant dentistry and will, in particular, have the opportunity to see how
experts overcome clinical challenges
that may present difﬁculties for the
majority of clinicians.
The scientiﬁc programme of the
2019 EAO congress was built around

The EAO congress is known as an
event that typically features the latest developments in implantology
and periodontics. Are there any particular developments in these ﬁelds
that you are aiming to highlight at
this year’s congress?
One of the things to have heavily
impacted the dental ﬁeld over the
last ﬁve years has been the advancement of digital technology, which has
made inroads into dentistry in many
different areas. In the beginning, digital procedures commenced in the
dental lab. Nowadays, it is possible to
conduct complete rehabilitation digitally from the beginning. From diag-

nosis and planning to fully guided
surgery and even the construction of
ﬁnal restorations—all of these steps
can be achieved with the use of digital tools.
With this progression in technology, many obstacles have been surpassed and difﬁculties overcome.
The deﬁnition of precision has
changed dramatically in the transition from an analogue environment
to a digital one. Enormous advancements in intra-oral scanning over the
past couple of years have taken
place, allowing this technique to
now be used in crown and bridge
planning, for orthodontic and periodontal reasons, and for impression-taking prior to implant procedures, to name just a few of its many
applications. The connection between the clinic and the dental lab
is much closer now owing to the optimisation of the digital workﬂow.
The connection between intra-oral
scanners, milling machines and 3D
printing, for example, is getting better every year. The general feeling
that I’ve experienced is that this
could be just the beginning of a huge
paradigm shift.
However, the evolution has been
happening in all different aspects of
dentistry. For example, new microsurgery techniques have been introduced, which have led to the development of micro-instruments that are
adapted for those speciﬁc techniques.
There are also new grafting materials
that simplify some surgical procedures, and research is being performed regarding the use of stem
cells, which may eventually be the
base for a substitute for dental implants at some point in the future.
These developments, I’m happy to
say, will be in the spotlight at the
2019 EAO congress.

Study introduces new surgical guide for placement of zygomatic implants
Dental patients who show a deﬁciency of bone volume cannot be
treated with root-form dental implants. Thus, new treatment modalities were sought for these patients.
One of the therapies considered was
the placement of zygomatic implants, which were introduced to the
market over 20 years ago. A recent
study has investigated a novel protocol for the placement of zygomatic
implants using a speciﬁc surgical
guide.
The protocol relied on large ﬁeld
of view CT/CBCT scan for an accurate assessment of the maxillary
arch to plan zygomatic implant receptor sites. A CT/CBCT-derived surgical guide of a novel design and an
exact replica of the entire maxilla
and zygomatic bone were fabricated
using 3D printing technology. Four
patients with completely edentulous
maxillary arches received a total of
ten zygomatic implants.
To evaluate whether the actual
surgical placement of the zygomatic
implants matched the computerised
planning and simulation, the preoperative positions were compared

with the postoperative positions by
merging the pre- and postoperative
scan data sets. The degree of accuracy of the superimposition was

measured utilising sophisticated
software. Apical, coronal and angular deviations were determined for
each implant. Deviations from the

computerised project to the actual
implant positions ranged from
2 to 3 mm, and angular deviations
ranged between 1.88 and 4.55°.

For more than 20 years, the use of zygomatic implants has been demonstrated to be a predictable and safe alternative treatment modality for complex
dental restoration in the maxilla and has exhibited a high rate of success.

28 th EAO Annual Scientiﬁc Meeting

The study found that the placement of zygomatic implants requires
surgical experience owing to the
close proximity of vital anatomical
structures. It used methods of superimposition that illustrated satisfactory correspondence between inserted implants and the virtual plan.
No adjacent vital anatomical structures were damaged. The novel surgical guide design afforded the surgeon visual control of the drilling
protocol. Positioning the guide in
close proximity to the entry point of
the zygomatic body aided control of
the drills up to the vicinity of the exit
point, signiﬁcantly limiting problems
associated with angular deviation.
The researchers concluded, “Reducing errors and complications is
essential for zygomatic implants to
remain a viable treatment alternative, and further research on a
guided approach to their placement
is encouraged.”
The study, titled “Computerguided approach for placement of
zygomatic implants: Novel protocol
and surgical guide”, was published
in Compendium.

[3] => TDI0819_01-16.pdf

Optimizing
time to teeth

Meet us

in Hall 2
booth C2022-24-26

Osstell helps you to objectively determine implant stability and to assess the
progress of osseointegration – without jeopardizing the healing process.

Achieve more predictable
outcomes

Shorten
treatment times

Manage patients with
risk factors

[4] => TDI0819_01-16.pdf

news

Researchers investigate possibility of regrowing teeth
For certain animals, the loss of
teeth does not always pose a problem:
sharks and crocodiles have the ability to regrow their teeth repeatedly.
Researchers from the Technische
Universität Berlin (TU Berlin) are exploring the possibility that this can
be applied to humans and are working on a new method to develop teeth
from the human body’s own tissue.
“It’s true that there are isolated
reports of people growing third teeth
or even a third complete set of teeth,
but why this should be possible for
some people and not for others remains unknown,” said Prof. Roland
Lauster, Head of the Institute of Biotechnology at TU Berlin.
“Essentially science assumes that
over the course of a lifetime the human
jaw also possesses the information necessary for the growth of new teeth,”
said Dr Jennifer Rosowski, research assistant to Lauster. The question is what
exactly triggers this process.
Under natural conditions, hair,
teeth and even nails grow as a result
of what is termed mesenchymal condensation. In the case of teeth, certain
precursor cells cluster together in the
jaw beneath the outer skin layer.
These cells condense and form a kind
of embryonic tooth germ. As a result

of this condensation, the embryonic
tooth germ begins to interact with surrounding cell layers in the jaw via speciﬁc messengers. “Within the tooth
bud created by this process, a differentiation of various cell types occurs: the
enamel organ, the dental papilla, and
the dental lamina. These tissues continue to differentiate until a complete
tooth is formed,” said Rosowski.
The approach adopted by the research team for the natural growth of
third teeth is as simple as it is ingenious. They remove dental pulp cells
from the interior of an extracted
tooth, and these are then cultivated
and dedifferentiated in such a way as
to produce an active embryonic tooth
germ. If this embryonic tooth germ
were to be implanted into a patient, it
would begin to communicate with
the surrounding tissue, initiating the
process of tooth development.
Competing research groups have
already provided conceptual evidence in an animal model system and
have demonstrated that an embryonic tooth implanted into the jaw actually develops into a complete tooth.
The TU Berlin research team,
however, sees a decisive competitive
advantage to their method. All other
competing research groups use em-

bryonic stem cells to produce embryonic tooth germs. “This makes a real
application of the process impossible
as the use of stem cells is ethically
highly contentious and not permitted
© TU Berlin/Tobias Rosenberg

Embryonic tooth germs are generated from dental pulp cells in a laboratory using a special method
of cultivation.

by law in most countries,” explained
Rosowski. “We would only use cell
material taken from the patient’s
own teeth. This enables us to bypass
all ethical and legal considerations,
providing us with the decisive advantage that our procedures focus on an
actual application of the body’s own
tissue. Using the body’s own tissue
means that no rejection reaction will
occur.”

Study determines reasons
for dental implant failure and
removal techniques
ing or maintaining osseointegration, or bone
overheating or site contamination. Late implant
failure is triggered by implant fractures, malpositioned implants and progressive peri-implantitis. The last causes 81.9 % of late implant failures. Early implant failure results in implants
that are normally mobile and easy to remove.
Late implant failure means the implants can be
at least partly osseointegrated and, therefore,
more difﬁcult to remove.
© Kasama Kanpittaya/Shutterstock.com
As options for implant removal, the
study determined tooth extraction, trephine burs, piezo-surgery, laser surgery, the counter-torque ratchet technique (CTRT) and electrosurgery. Even
though trephine burs seem to be the
best-known method for implant removal, the CTRT method, alone or combined, should be the ﬁrst choice for the
clinician because of its low invasiveness.

According to a recent study, peri-implantitis is currently the main reason
Furthermore, the research team
for dental implant failure.
found that implantation in previously
failed sites, irrespective of early or late failure,
visited the reasons for implant failure and comresults in a 71–100 % survival rate over ﬁve
pared different removal techniques.
years.
A literature search included 28 studies
Regarding zirconia implant removal, little
which had been conducted up to 2018. The studdata is available. Because of zirconia’s physical
ies assessed titanium implant failure, removal
properties, it is supposed that these implants retechniques and the reinsertion of implants in a
quire a different approach to removal compared
previously failed site.
with titanium implants.
The research team identiﬁed different cate“If removal is required, interventions
gories of factors causing implant failure. Biologshould be based on considerations regarding
ical factors include peri-implantitis and failure
minimally invasive access and management, as
to attain or to maintain osseointegration. Imwell as predictable healing. (Post)Operative conplant fracture is an example of a mechanical
siderations should primarily depend on the defactor. Medical errors causing implant failure infect type and the consecutive implantation
clude bone overheating, site contamination and
plans,” concluded the authors in their paper.
malpositioning. Functional reasons for implant
The study, titled “Removal of failed dental
failure include design of prosthesis and funcimplants revisited: Questions and answers”, was
tional overload.
published in Clinical and Experimental Dental
The researchers found that early implant
Research.
failure is normally caused by the lack of attain Dental implants have become a great treatment option to replace missing teeth, and various treatment concepts have reported high success rates. Nevertheless, like in every medical
procedure, biological complications can occur
which may lead to complete implant failure and,
consequently, in the worst-case scenario, to the
removal of the implant. A recent study by researchers from the University of Zurich has re-

28 th EAO Annual Scientiﬁc Meeting

The Department of Oral and Maxillofacial Surgery at Charité–University Medicine provides the researchers with the teeth they require for
their research in the form of ex-

tracted third molars. The researchers
have developed a special cultivation
method to allow the adult cells in
these teeth to dedifferentiate back
into a type of embryonic state and ﬁnally form an embryonic tooth germ.
The dental pulp cells are isolated,
cleansed and then cultivated in microtitre plates whose upper surfaces
have been coated with a hydrogel.
The hydrogel prevents the cells ad-

hering to the walls of the plates. They
ﬂoat freely in the medium but are actually programmed to achieve a 3D
structure. As a result, they condense
independently, without external pressure, into a kind of cell ball. This process takes 24 hours and the resulting
ball is about 200–500 μm in size.
“We are the only group worldwide who have been able to demonstrate that this process of creating a
ball through independent mesenchymal condensation triggers the
expression of various genes, thus
setting in motion the production of
speciﬁc messengers. These messengers are required to interact with
the surrounding jaw tissue,” said
Rosowski about the method, which
has since been patented globally. In
order to prove the validity of this,
the researchers co-cultivated the
embryonic tooth germs together
with gingival cells. During embryonic tooth development, these two
cell types interacted, initiating tooth
formation. Thus, the researchers
were able to prove precisely this interaction.
Now that all the in vitro tests
have been successfully completed,
the embryonic tooth germs are ready
for the ﬁrst preclinical tests.

Long-term study
analyses risk factors
for short dental implants
The use of standard dental implants has become a widely accepted treatment modality for
the rehabilitation of complete and partial edentulism. However, in severe alveolar resorption,
standard-length implant placement is not possible without additional surgical intervention. For
such cases, the use of short implants is considered a major contribution to the ﬁeld of implant
dentistry. Now, a study has determined the risk
factors for short dental implant survival.
The study, conducted by the Ankara Yildirim
Beyazit University in Ankara, the Cumhuriyet
University in Sivas in Turkey and a private dental practice in Ankara, aimed to identify the different implant- and patient-related risk factors
for long-term short dental implant success.
Through a retrospective chart review of three
centres, patient information regarding demographic variables, smoking habits, history of
periodontitis and systemic diseases, and medications was collected. In addition, information was
gathered relating to the parameters for short implant placement, including implant manufacturer, design, anatomical location, diameter and
length, and type of placement.
For the statistical analysis, univariate regression models were used at implant and pa-

tient levels. A total of 460 short implants—ranging from 4 to 9 mm in length—placed in 199 patients and followed up for up to nine years were
reviewed. Survival rates of the short implants
were 95.86 % and 92.96 % and success rates
were 90.00 % and 83.41 % for implant- and patient-based analysis, respectively. Peri-implantitis was reported as the cause of short dental implant failure in 73.91 % of the cases. Univariate
regression models revealed that the female sex
was strongly related to short implant success. In
addition, smoking and a history of periodontitis
were found to have a signiﬁcant negative inﬂuence on short implant success at the implant and
patient levels.
These results support the use of short implants as a predictable long-term treatment option; however, smoking and a history of periodontitis are suggested to be the potential risk
factors for short implant success. According to
the researchers, these outcomes are consistent
with the ﬁndings of other long-term studies.
The study, titled “Risk factors associated
with short dental implant success: A long-term
retrospective evaluation of patients followed up
for up to 9 years”, was published in Brazilian
Oral Research.
© DenDor/Shutterstock.com

In a long-term study, researchers have reported high survival rates for short dental implants.

[5] => TDI0819_01-16.pdf

news

Review study compares
machined and sandblasted dental implant surfaces
Previous studies have suggested
that surface roughness is one of several key factors that inﬂuence the degree of biological integration and success rates of implants. Although attention and utilisation has shifted
from machined to sandblasted surfaces, for clinical practice, no sound
and strong evidence exists to support
the use of sandblasted implants over
machined ones. Therefore, researchers from the Semmelweis University
in Budapest, Hungary, compared implant failure and marginal bone loss
between the two in a systematic review and meta-analysis.
During the blasting process, ceramic particles such as titanium oxide, aluminium oxide or silica are
blasted on to the implant surface at
high velocity. The size of the sand
particles and their speed when they
reach the implant surface are the key
parameters that inﬂuence surface
roughness. Sandblasted implants
have a rather irregular, rough surface
and machined surfaces are smoother
with only shallow grooves.
According to the researchers,
several in vitro studies have demon-

The results indicated an 80 % lower
risk ratio among sandblasted compared with machined implants after
one year of use and a 74 % risk ratio
after ﬁve years of use, respectively. In
contrast, there was no signiﬁcant difference in marginal bone loss be-

tween the two implant surfaces after
one and ﬁve years of use.
The researchers concluded: “This
meta-analysis reveals that sandblasting is superior over machined surface
in implant failure but not in marginal
bone level in healthy subjects. It also

points out the need for further randomised clinical trials with large
sample size for objective determination of the clinical beneﬁts of certain
implant surface modiﬁcations.”
The study was conducted in collaboration with the University of

IT’S TIME FOR
ATRAUMATIC
EXTRACTIONS
50%

(2)

less pain &
swelling

20%

A study found that sandblasted and machined
dental implant surfaces differ in survival rates
but not in marginal bone loss.

strated the positive effects of sandblasted surfaces on osseointegration.
However, some preclinical and clinical investigations and reviews have
indicated that moderately rough surfaces may not perform better. These
studies suggest that a rougher surface may modify the properties of bioﬁlm formation and, therefore, bacteria could attach to the surface more
easily. Hence, the marginal bone
around rough implants may be less
stable and more vulnerable to periimplantitis.
The systematic review included
seven studies, involving 362 sandblasted and 360 machined implants.

Pécs and the University of Szeged,
both in Hungary.
The study, titled “Sandblasting reduces dental implant failure rate but
not marginal bone level loss: A systematic review and meta-analysis”,
was published in PLOS ONE.

98%

(3)

less analgesics
intake

(1)

faster

(1) Tests conducted with Piezotome® Cube Star compared to different devices in our laboratory measuring the difference of the depth created by each device in a given time with the same force applied to the handpiece
(2) Shanghai Kou QiangYi Xue. Comparative study of complications among routine method, high speed turbine handpiece and piezosurgery device after extraction of impacted wisdom teeth. Shanghai Journal of
Stomatology. 2012 Apr;21(2):208-10.
7URHGKDQ$.XUUHN$:DLQZULJKW08OWUDVRQLF3LH]RWRPHVXUJHU\LWLVDEHQHȴWIRURXUSDWLHQWVDQGGRHVLWH[WHQGVXUJHU\WLPH"$UHWURVSHFWLYHFRPSDUDWLYHVWXG\RQWKHUHPRYDORILPSDFWHGPDQGLEXODU
3rdmolars. Open Journal of Stomatology. 2011;1:179-184

Class IIa medical devices - CE0459 (GMED) - Manufacturer: SATELEC® - France.
For dental professional use only.
Updated on: 08/2019
SATELEC® S.A.S A Company of ACTEON® Group
17 av. Gustave Eiffel ZI du Phare 33700 MERIGNAC cedex FRANCE
Tel + 33 (0) 556 340 607 Fax + 33 (0) 556 349 292
E-mail: info@acteongroup.com www.acteongroup.com

28 th EAO Annual Scientiﬁc Meeting

[6] => TDI0819_01-16.pdf

news

Dental implants are medically advisable for patients with Sjögren’s syndrome
Up until now it was not known
whether dental implants were successful in patients affected by
Sjögren’s syndrome. In fact, many
professionals advise against them, as
they believe these patients have a
higher risk of implant failure. However, researchers at the universities
of Malmö and Gothenburg in Sweden

have found that dental implants are
a viable option for people with
Sjögren’s syndrome, even though
these patients may experience a
higher marginal bone loss around
their implants than others.
Sjögren’s syndrome is a systemic
disease characterised by the progressive destruction of some glands, par-

ticularly those around the eyes and
mouth. “It is known to reduce the saliva ﬂow, resulting in a dry and very
sensitive oral mucosa. Patients may
more rapidly lose their teeth caused
by caries and periodontitis compared
with patients who are not affected by
this disease,” co-author Dr Ann Wennerberg from the Department of Prost-

hodontics at Sahlgrenska Academy at
the University of Gothenburg told DTI.
“The very small amount of saliva results in a lack of necessary lubrication,” continued Wennerberg. She explained that this would cause the patient soreness and pain. “For patients
with Sjögren’s syndrome removable
dentures may be impossible to wear,”

she added. As a result, many affected
patients turn to dental implants.
The researchers conducted the
study in two parts. First, they reviewed a clinical series of 19 Sjögren’s
patients who, together, had received
107 dental implants. Second, they
conducted a review of published literature and assessed the cases of 186
patients who had received a total of
712 implants, of which 705 were followed up.
Through the clinical series, the
researchers found that, out of 19 patients, two patients lost three implants, together, which led to a failure
rate of 2.8 %. All failed implants were
caused by a lack of osseointegration.
The implants were followed for a
mean period of ten years. At the last
follow-up, the mean marginal bone
loss for patients was −2.19 mm. The
research team estimated the marginal bone loss after 30 years at
4.39 mm.
© madeinitaly4k/Shutterstock.com

A study has found that patients affected by
Sjögren’s syndrome, in contrast to the general
assumption, demonstrate quite a high survival
rate of dental implants.

A study found that sandblasted and machined
dental implant surfaces differ in survival rates
but not in marginal bone loss.

28 th EAO Annual Scientiﬁc Meeting

From the literature review, the
researchers found that, out of the
705 implants—which were followed
up for approximately six years—
29 failed, resulting in a failure rate of
4.1 %. After conducting statistical
analysis, researchers found that the
probability of failure was 2.8 %.
When stratifying patients based
on primary or secondary Sjögren’s
syndrome, the researchers found that
those with primary disease had a
lower failure rate of implants of 2.5 %
compared with patients with secondary Sjögren’s syndrome. These patients showed a failure rate of 6.5 %.
“The results show that a treatment with dental implants can be
done with a good prognosis, in contrast to what has been feared. However, the results also demonstrate the
marginal bone resorption to be higher
than for patients without the syndrome. This is indicative for the need
for regular control visits to the dentist
and short intervals between appointments to a dental hygienist,” concluded Wennerberg.
The study, “Dental implants in
patients with Sjögren’s syndrome:
A case series and a systematic review”, was published in the International Journal of Oral and Maxillofacial Surgery.

[7] => TDI0819_01-16.pdf

Introducing INVERTA™
from Southern Implants
Optimizing Predictable
Anterior Aesthetics
• Innovative Body-Shift™ Implant Design
• Apical bone engagement for
immediate implant placement
• Coronal chamber for bone growth
and natural aesthetics
• Popular Co-Axis® Connection with
Subcrestal Angle Correction®

“To be able to use
INVERTA Implants
in aesthetically
challenging cases
gives me a
predictable
outcome with
limited buccal

Visit us at
Stand A26

recession and
healthy soft
tissue.”
- P.O. Östman, DDS,
PhD, MD
Falun, Sweden

Want to Learn More?
Register for the INVERTA hands-on workshop:
Friday 27 September, Room 12
Hugo De Bruyn, DDS, PhD
Pär-Olov Östman, DDS, PhD

SOUTHERNIMPLANTS.COM
©2019 Southern Implants (Pty) Ltd. All rights reserved. Co-Axis, Southern
Implants and Subcrestal Angle Correction are registered trademarks and
Body-Shift, and INVERTA are trademarks of Southern Implants
(Pty) Ltd. Not all implants are available in all markets. PRO131 Rev A 08/19

[8] => TDI0819_01-16.pdf

ﬂoor plan

Hall 2

Hall 1

E04

HOSPITALITY
SUITE 1

HOSPITALITY
SUITE 2

HOSPITALITY
SUITE 3

O
TO
LL
HAL
2
B60

A25

TO E-POSTERS
ZONE

C51

B62

F07

D27

A26
C49

B54

D28

F09

F11

G06

G08

G09

G07
D23

F18

F20

F19

F21

G10

G14

HOSPITALITY
SUITE 5

H08

H06

G11

G17 - G19

G13

G21

G15

H12

D22

A22
D21
B48

F15

F13

HOSPITALITY
SUITE 4

E05 - E07

D26

D25

B43

E01

EAO CHANNEL
STUDIO

H03

H09

H11

H13

ASSOCIATIONS
CORNER

D20

C35

A20

D19
B42

H15
D18

H17

C38

C33

A18

D16

B39

C31

B38

TO
HALL
1

A15
D14

C30
B35
A11

TO HALL 3
TO FIRST FLOOR
CONFERENCE ROOMS

D10
C28

A10

A09

C27

B31

Hall 3

D07
D08

A08

TO HALL 1

B28
C25

K01

D04

B22

C20

D03

K02

A04
B17
D01

B18
A01

C12

C15

A02

I01 J02

J01–K03

K04

I03 J04

J03–K05

K06

ROOM 9

D02

ROOM 10

B14

Mezzanine

Mezzanine
C08

B07
B08

B10

C09

L04

C07
C06

B01
B02

B04

C05

L06

C03

TO
E-POSTERS
ZONE
REGISTRATION

I05 J06

TO
REGISTRATION

K12

ENTRANCE

HALL 1
HALL 3
HALL 2

ENTRANCE
This ﬂoor plan is a reproduction of the ﬂoor plan by the EAO. Changes or modiﬁcations may occur.

8

28 th EAO Annual Scientiﬁc Meeting

L07

TO
HANDS-ON SESSIONS ROOMS 11, 12, 13

[9] => TDI0819_01-16.pdf

list of exhibitors

Company

Hall/Booth

3

Company

Hall/Booth

D

3SHAPE

2/B35

A

DATUM DENTAL

1/G17–G19

Company

Hall/Booth

I-RES GROUP

2/B18

3/K12

JDENTALCARE

ACE SURGICAL SUPPLY COMPANY

1/C07

DENTAL RATIO

2/C06

K

ACTEON GROUP

1/H03

DENTIUM

2/B17

KLOCKNER IMPLANT SYSTEM

DENTSPLY SIRONA

2/C27

L

ALFA GATE

3/J01–K03

ALPHA BIOTECH

2/B14

DIO IMPLANT

2/C35

LIFENET HEALTH

AMERICAN DENTAL SYSTEMS

1/H13

DR-KIM CO.

2/D02

M

ANTHOGYR

2/D23

E

ASEPTICO

2/C07

EMS ELECTRO MEDICAL SYSTEMS

AVINENT IMPLANT SYSTEM

2/D10

B

Q

2/B01

2/D04

2/B02

1/H17

R

Company

Hall/Booth

SUNSTAR

2/A22

SURGIDENT CO.

3/L04

SWEDEN & MARTINA

3/I05

REGEDENT

2/A08

T

RHEIN’83

1/G08

THOMMEN MEDICAL

2/B22

RUETSCHI TECHNOLOGY

1/H06

TI-OSS OCTABONE

2/D28

TRATE

2/B48
2/B38

S
S.I.N. IMPLANTS

2/D27

TRI DENTAL IMPLANTS

MALO CLINIC

2/A10

SAEYANG MICROTECH CO.

1/F21

TRUABUTMENT

1/F18

MAXILLARIS

3/K02

SANHIGIA THINK SURGICAL

2/B60

U

EURONDA

2/A18

MECTRON

1/G15

SAUDE ORAL

3/J04

UBGEN

2/D01

EXAKTUS

2/B08

MEDENTIKA

2/HS2

SHINHUNG CO.

2/A04

USTOMED INSTRUMENTE

1/H09

2/A02

MEDENTIS MEDICAL

1/H11

SHINING 3D TECH CO.

2/D21

V

SIC INVENT

2/D25

VERSAH

B&B DENTAL IMPLANT COMPANY

2/D08

EXOCAD

BEGO IMPLANT SYSTEMS

2/B43

F

BEIJING YHJ SCIENCE

Hall/Booth

QUINTESSENCE PUBLISHING

J

DENTAL PRO

Company

MEDICAL INSTINCT

1/E05–E07

3/J02

FORESTADENT IMPLANTS

2/D18

DEUTSCHLAND

1/H08

SK BIOLAND CO.

2/A25

W

2/B04

MEDIDENT ITALIA

2/D26

SOUTHERN IMPLANTS

2/A26

W&H GROUP (W&H + OSSTELL)

MEDIT

1/E01

SPEMD

3/K04

Y

AND TRADE CO.

3/I03

FOTONA

BIEN-AIR DENTAL

1/G14

G

BIOHORIZONS CAMLOG

2/C25

GEISTLICH BIOMATERIALS

2/C31

MEGAGEN IMPLANT

2/A01

SPERO

3/K06

YUNYI MEDICAL DEVICE CO.

BIOMEDICAL PRF-BRGF

3/I01

GLOBAL D

2/D07

MEISINGER

1/F07

SPPI

3/K01

Z

BIOMEDICAL TISSUES

2/A09

H

META

2/B07

S-TECH

2/D22

ZEST DENTAL SOLUTIONS

BIONNOVATION BIOMEDICAL

2/D20

HU-FRIEDY

MIS

2/C28

STOMA/STORZ AM MARK

1/G11

ZIBONE

1/G09

BIOTECH DENTAL

1/G10

I

STRAUMANN

2/HS2

ZIMMER BIOMET

2/C30

BLUE M

1/G06

IBI SA SMARTBONE

2/D19

NEODENT

2/C49

BOTISS BIOMATERIALS

2/A15

IBS IMPLANT

2/C51

NEOSS

1/E04

IMPLACIL DE BORTOLI

1/F15

NIBEC CO.

2/B42

NOBEL BIOCARE SERVICES

2/C15

BREDENT GROUP

2/D14–D16

2/A20

N

BRESMEDICAL

1/G13

IMPLANCE DENTAL

BTI BIOTECHNOLOGY INSTITUTE

2/B39

IMPLANT SYSTEM

2/C08

NOVABONE PRODUCTS

1/F11

IMPLANTSWISS I-SYSTEM

2/C12

NSK

2/B10

NUCLEOSS

2/D03

NYU DENTISTRY

1/H12

C
CARESTREAM DENTAL

2/C33

INTERNATIONAL TEAM

CLARONAV

2/C09

FOR IMPLANTOLOGY

CURAPROX

1/F19

INVIBIO BIOMATERIAL SOLUTIONS 2/B62

1/F20

about the publisher

International Ofﬁce/Headquarters
Dental Tribune International GmbH
Holbeinstraße 29, 04229 Leipzig, Germany
Phone: +49 341 48474-302
Fax:
+49 341 48474-173
E-mail: info@dental-tribune.com
Internet: www.dental-tribune.com

Production Executive
Gernot Meyer
Advertising Disposition
Marius Mezger
Production
Matthias Abicht

Publisher/Chief Executive Ofﬁcer
Torsten Oemus
Chief Financial Ofﬁcer
Dan Wunderlich
Director of Content
Claudia Duschek
Managing Editor
Franziska Beier
Assistant Editor
Brendan Day
Business Development & Marketing Manager
Alyson Buchenau
Sales & Production Support
Puja Daya, Hajir Shubbar, Madleen Zoch

today will appear at the 28th EAO Annual Scientiﬁc Meeting
in Lisbon, 26 –28 September 2019. The newspaper and all
articles and illustrations therein are protected by copyright.
Any utilisation without prior consent from the editor or publisher is inadmissible and liable to prosecution. No responsibility shall be assumed for information published about
associations, companies and commercial markets. General
terms and conditions apply; legal venue is Leipzig, Germany.
© 2019, Dental Tribune International GmbH.
All rights reserved. Dental Tribune International makes every
effort to report clinical information and manufacturer’s
product news accurately, but cannot assume responsibility
for the validity of product claims, or for typographical errors.
The publishers also do not assume responsibility for product names, claims, or statements made by advertisers.
Opinions expressed by authors are their own and may not
reﬂect those of Dental Tribune International.

O
OMNIA

2/B31

ORTHOCELL

2/C05

OSSTELL

2/C20

OSSTEM IMPLANT

2/C38

OSTEOBIOL BY TECNOSS

2/B28

OSTEOGENICS BIOMEDICAL

1/F13

OSTEOLOGY FOUNDATION

2/A11

OXY IMPLANT

2/C03

P
PENGUIN RFA

1/F09

PLANMECA

2/B54

PURGO BIOLOGICS

1/H15

2/C20

1/G21

3/J05–K05

AD

is coming to

PRAGUE
21–24 May 2020
Prague, Czech Republic

www.ROOTS-SUMMIT.com

28 th EAO Annual Scientiﬁc Meeting

9

[10] => TDI0819_01-16.pdf

industry

ICD—Honouring the world’s leading dentists since 1920
An interview with Dr Dov Sydney, by Nathalie Schüller, DTI.
The International College of Dentists (ICD) will celebrate its centennial in 2020. The ICD is the oldest and
largest honour society for dentists in
the world and was conceived by Drs
Louis Ottofy and Tsurukichi Okumura with the vision of an organisation of outstanding dentists to maintain professional collegiality and
friendship, monitor and evaluate the
progress of dentistry internationally,
and disseminate such information to
dentists worldwide.
Today, the ICD has 12,000 fellows
in 122 afﬁliated countries, from a diversity of cultures and social backgrounds and with different professional experiences. It aims to recognise their outstanding contributions
to the dental profession in upholding
the college core values of leadership,
recognition, humanitarianism, education and professional relations. On behalf of Dental Tribune International, I
had the pleasure of speaking with Dr
Dov Sydney, the International Editor
and Director of Communications, as
well as the Chair of the College Centennial Committee.
Dr Sydney, tell me how and why you
became involved in the ICD.
It was in a manner very typical of
the ICD. I had a patient who was a
dentist and told me about the voluntary work he was doing for an ICD
clinic for blind people. I had no idea
then what the ICD was about. He told
me more about the ICD and asked
whether I would like to become involved in the clinic to help the patients, and based on my background
and CV, said he would like to nominate me to become a fellow. That was
in 1996 and I was proud to agree. I
was active in the Israel District and
then moved to the European Section
board as regent, editor and website
manager. Later, I was asked to serve
on the worldwide executive of the organisation as the International Editor
and Director of Communications for
the ICD.
While our organisation is focused
on improving access and quality of
oral health, we are also a professional
society of shared interests and values, so there is also the meaningful
fellowship and camaraderie aspect:
we meet at regional and international
levels for both serious discussions
and social events. This is a unique
group in which there is the absence
of an atmosphere of competition and
the need to show how successful one
is or how many papers one has published. This is uncommon in many
professional associations. I feel everybody is aware of and appreciates this
unique aspect of the ICD. The ICD
promotes a collaborative, sharing relationship guided by the universal
principle that all members are equals
regardless of their national origin,
culture or language.
Are all potential members nominated
by fellows?
Yes, one has to be nominated by
two fellows in good standing. Let’s
say a candidate lives in Germany.
Two members of the college would
have to recommend the person to the

German District committee, who, following recommendation from the credential review committee, would
pass the recommendation on to the
full European Section board (consisting of all 35 European member countries) for a vote on the nomination.
The decision would then pass on to

a bad toothache, one cannot function;
if one loses one’s teeth, one cannot
eat. In many parts of the world where
nutrition is poor, without functional
teeth to eat properly and digest food,
overall health is affected. Furthermore, there are places in the world
where dental infections are so neg-

tive. We work with the Centers for
Disease Control and Prevention in Atlanta in the US and the World Health
Organization to put on programmes
teaching dentists how to deal with antibiotic resistance. We also provide
programmes on sepsis and sterilisation.

From left: Pope Francis, Dr Mauro Labanca and Dr Dov Sydney.

ICD world headquarters for completion of the process and preparation of
certiﬁcates. So, the process does take
time, but that is to ensure thorough
scrutiny of requirements and documentation inherent in the peerreview procedures.
What is the basic requirement to be
nominated? Are accomplishments in
dentistry, humanitarian work or both
required?
Nominees have to have made major contributions to dentistry in more
than one of the following areas: academia/teaching, research, humanitarian programmes, leadership or service projects. In other words, they
must have had a signiﬁcant impact
on dentistry and society.
What is your major joy, your main
motivation, in being part of the ICD?
As the International Editor and
Director of Communications, I see all
of the reports and images of ICD
events and projects that take place
around the world.
I have to select the ones that will
appear online and in our journal.
That is why I sent you a photo of the
2015 issue of The Globe, the ICD journal. In this photo, one can truly see
the kind of impact so many of our projects have on the people who are the
recipients of ICD compassion and
dedication. It is evident in their
eyes—a palpable image of someone’s
unselﬁshness, caring for another human being, some receiving care for
the very ﬁrst time in their lives.
Is dental care the main thing we
should worry about in parts of the
world that are so destitute?
Oral disease is usually treatable,
often preventable, and yet if one has

28 th EAO Annual Scientiﬁc Meeting

lected and serious that they can lead
to major disease states and even
death.
Another strength of the ICD is
that we look at the overall impact of
our projects on the community. I recall reporting on a group that went to
Nepal to help children in great need
of dental care. When the team arrived, they encountered unexpected
problems. The community was suffering from mass diarrhoea, a major disease in the Third World. People can
become extremely ill and die from
not having access to clean running
water. The water used to brush the
children’s teeth was contaminated.
The team developed a programme to
bring running water into the village
for toilets and sinks for toothbrushing. The rate of diarrhoea went from
75% to 5%. Children were able to go
back to school. The adults could
work. This is a good example of how
ICD dental projects can have a major
impact on a community and the overall health of the project site’s population.
How are ICD projects initiated?
There are many kinds of projects.
Some are directly funded through the
ICD’s Global Visionary Fund. Also,
there are 15 sections of the college
and they have their own foundations
or funds to initiate their own projects.
Many fellows are also involved in individual ICD projects. Soon, we will
be introducing an interactive map of
hundreds of projects on our website
where a visitor can see educational
projects, student exchange programmes, humanitarian missions
and more. We currently have a major
programme on antibiotic resistance
owing to the fact that antibiotics today are becoming less and less effec-

You had the very special honour of
representing the ICD in a meeting
with Pope Francis at the Vatican.
What was the experience like?
Actually, I met the Pope with Dr
Mauro Labanca, who spent more
than a year on making the baciamano
(literally “hand-kissing”), a meeting
with the Pope, possible. The moment
the Pope met us was an amazing experience to say the least. Standing
with him, shaking hands, and engaging in conversation with one of the
most iconic individuals in the world
was inspiring and surreal. Of course,
the news coverage of the event
bought the college fellows a tremendous sense of pride in our society,
having been recognised on the world
stage, and receiving the Pope’s support for the centennial was very
much appreciated.
Next year will mark the 100-year anniversary of the ICD. What are the
changes, progress and developments you are the happiest about
today?
The fact that we grew from a concept ﬁrst established by a Japanese
dentist and an American dentist
meeting a 100 years ago endeavouring to have an international organisation to today, with the largest footprint of any dental honour society in
the world, says a great deal. The integrity of the organisation throughout our 100 years in recognising
those dentists who truly demonstrate
having made major contributions to
dentistry and society has been consistent. We are not a very well-known
organisation; in fact, many dentists
are unaware of the ICD. We realise
that, in order to honour our motto of
“recognizing service as well as the
opportunity to serve” and to be true

to the vision of our founding fathers,
we do have to make ourselves better
known in order to ensure that deserving dentists are recognised by the college.
The centennial is a watershed
moment for the college and validates
that the ICD core values are sustainable and worthy. The projects, the organisation and the dedication of our
members to improving oral health
care are only possible because our fellows deeply believe in what they are
doing; had they not, the ICD would
have disappeared long ago.
What do you think are the major
challenges facing the college today?
All major organisations in dentistry are seeking new members.
Some have little or no oversight or require little, if any, performance evidence as a prerequisite to membership, unlike the ICD, whose requirements are considered of the most
stringent of all recognition-based international dental honour societies.
Quite frankly, some try to imitate
how the ICD operates, and why not?
The ICD is in the enviable and unique
position of having recorded sustained
membership growth for the last ten
years. We have a strong and consistent contact relationship with our
members by focusing on meeting fellows’ needs, staying relevant and consistently seeking out new and innovative methods to enhance our communications and connection with them.
But, with the constant bombardment of information via the Internet
and e-mails, there are many challenges and media competition for our
members’ attention. We are meeting
those challenges with innovative
communication packaging, but it’s a
constant and unending endeavour.
We have already touched on the
ideas of friendship and passion of
ICD fellows. What is the main ingredient of the ICD’s success to you?
Dedication and commitment to
ICD core values is the common denominator; ICD fellows are driven as
individuals and as a group to improving dentistry and the life of those being underserved. One sees that everywhere we have an ICD presence.
The celebration of the 100-year anniversary is planned to be a worldwide
event; every section, district and region will be holding events. Can you
tell us a bit more about what we can
expect before the grand ﬁnale in
Nagoya in Japan in 2020?
As mentioned earlier, we have
15 sections, 70 districts and 15 regions worldwide, and they will be
participating in different ways to acknowledge the 100-year anniversary.
Every ICD jurisdiction will have an
event during 2020 that will memorialise that special year and will lead
up to the very special ﬁnale in Nagoya in November 2020. There will
be a ceremony in Nagoya in which
new inductees from all over the world
will participate in an Olympic-style
event, in addition to a gala banquet,
special entertainment and many surprises!

[11] => TDI0819_01-16.pdf

Targeting Perfection
Dynamic navigation for freehanded dental
implant placement
6HHIRU\RXUVHOIKRZIUHHKDQGHGJXLGHGVXUJHU\DLGVPRUHDFFXUDWHLPSODQWSODFHPHQW1DYLGHQWWUDFNV
WKHGULOODQGWKHSDWLHQW·VMDZSURYLGLQJUHDOWLPHWDFWLOHJXLGDQFHDQGYLVXDOIHHGEDFN

The smallest footprint
in your practice,
the largest impact
on your practice
NOW supporting:
- Implant surgery
- Root canal treatment
- Piezotome bone surgery

Compatible with any implant type, drill system and all CBCTs currently on the market
Precision guidance for increased accuracy
within 0.5mm of treatment plan

Provides even greater value from
your CBCT data

Easy to use, reducing time and expense
ZLWKDVLPSOLÀHGZRUNÁRZ

(QDEOHVPLQLPDOO\LQYDVLYHÁDSOHVV
drilling without a physical guide

Try Navident’s precision guidance for yourself.
Call +32.475.75.52.26 or email info@claronav.com
Visit us at Stand C09 at EAO 2019

www.claronav.com

*Average error of 0.4mm in internal bench tests with a range of operating conditions.

,QWHUDFWZLWKFOLQLFDOH[SHUWVLQWKHÀHOGRIG\QDPLF
navigation at EAO 2019.
Meet the Expert sessions will be held during the meeting in our booth on
Thursday, September 26 and Friday, September 27.
These sessions provide participants with the opportunity to be updated
about clinical cases performed with Navident in a highly interactive
manner. Each session will consist of informal discussions arising from its
question and answer format.
Visit dns.claronav.com for more info on tailor-made courses about
dynamic navigation.

Learn more at EAO 2019. We are located at Stand C09.

[12] => TDI0819_01-16.pdf

industry

“Osstell’s technology remains the deﬁnitive method
for measuring and understanding implant stability”
An interview with Prof. Neil Meredith, co-founder of Osstell and resonance frequency analysis, by DTI.
At the 28th Annual Scientiﬁc Meeting of the European Association for
Osseointegration (EAO 2019), Prof.
Neil Meredith will be one of three
speakers at the Osstell Scientiﬁc
Symposium. He has been placing and
restoring dental implants for over
30 years and is a co-inventor of resonance frequency analysis (RFA) for
dental implants, the diagnostic technique that led to the formation of
Swedish company Osstell. Currently,
he works as Professor of Prosthodontics at the University of Queensland’s
School of Dentistry in Brisbane in
Australia and Professor of Dental
Science at James Cook University’s
College of Medicine and Dentistry in
Townsville in Australia. He has lectured and published widely and internationally, but his real passions are
clinical patient treatment and teaching. He spoke with Dental Tribune International about the upcoming symposium and Osstell Connect, and
looked back on 25 years of Osstell’s
company history.
Prof. Meredith, you will be giving a
lecture titled “Osstell Connect: The
key to unlocking clinical success” at
the Osstell symposium today at EAO

2019. On what topics will you focus
during your presentation?
Osstell’s technology has been
used as the deﬁnitive method for clinical measurement of implant stability
for over 20 years. It is widely accepted
as a clinical measurement technique
to guide treatment choices, as well as
an academic method for comparisons
in studies and research. In addition to
being reported on in over a thousand
scientiﬁc publications, tens of thousands of clinicians worldwide use
Osstell’s technology routinely every
day in their clinical practice.
The world today is about data, its
collection and its use in every aspect
of our lives. It is impressive that
Osstell Connect is the only dental
technology available to collect, process and present data on a worldwide
basis to every Osstell user to help him
or her achieve the highest levels of
clinical success and support in clinical audit. Data is measured with instruments like Osstell Beacon or
Osstell IDx, and uploaded to a global
database. This not only enables clinicians to save their data securely and
in a user-friendly format, without the
need for local notes or backup, but
the database tracks each patient, pro-

The company is inviting
all attendees of EAO 2019 to join the 11th annual Osstell Scientiﬁc Symposium
at EAO 2019 in Lisbon on 26 September (10:15–12:15). The symposium
features four distinguished speakers: Prof. Neil Meredith (Australia), co-inventor
of RFA and Osstell; Dr Jeffrey Ganeles (USA); Dr Barry Levin (USA); and Dr Marcus
Dagnelid (Sweden), moderator. The speakers will discuss “Evidence-based guidance for implant loading—sharing knowledge for predictable treatment outcomes”. Those interested in attending can ﬁnd more information on and register
for the event at content.osstell.com/eao.

viding useful graphs and information.
Osstell Connect provides more
than data connected to individual clinicians but will also enable them to
compare worldwide information
about patients, techniques, implant
systems, grafting and much more.
As a clinician, how has your personal
experience with Osstell Connect
been?
Very good! Osstell Beacon is very
simple to use but is still a sophisticated instrument. On its own, it displays ISQ (Implant Stability Quotient)
values for both directions, which is
essential. In addition, a coloured indicator displays green (good), amber
and red (caution). Data is sent seamlessly via Bluetooth to the Osstell
Connect database open on the computer. Osstell Connect is a very easy
and useful way of saving and tracking patient data. It presents useful
graphs and also allows comparison of
data with overall and worldwide information.
Being a Web-based database,
Osstell Connect does not require the
clinician to do a backup or software
update, since this is performed centrally by Osstell, ensuring reliability.
How has the device been received by
users so far, and what can dental
practitioners expect from it in the
future?
Osstell Beacon has been very
well received. Clinicians are impressed that such a compact instrument can be so sophisticated and yet
remain very easy to use. As it is wireless, recharging is simply done via a
USB-C socket and it has a great battery life.

Beacon is excellent as a
stand-alone instrument, but
with Osstell Connect, it is so
easy to capture data. This gives
clinicians access to a very powerful online database and also
provides a simple way for them
to download and analyse their
own data. There is an ever-increasing demand on clinicians
to record as much patient information as possible for legal and
audit purposes. Osstell Beacon
and Connect form a readymade, internationally recognised
platform designed to assist the clinician. In addition, Osstell Connect is
supplied without charge.
As the database grows, Osstell
Connect will offer statistics and information collated from its worldwide
database that will enable every clinician to identify the best techniques,
materials and systems to achieve the
highest level of success for his or her
patients.
The Osstell Scientiﬁc Symposium
will be held under the theme “Evidence-based guidance for implant
loading—sharing knowledge for
predictable treatment outcomes”.
What would you say dentists can
look forward to?
The Osstell symposium has become a tradition at the EAO meeting,
welcoming internationally recognised clinicians and experts not only
to share in the beneﬁts of Osstell but
also to see how clinical techniques
can be optimised and enhanced. I believe that this meeting will be pivotal
in demonstrating how, for the ﬁrst
time, real-world clinical data can beneﬁt us all in the treatment of our patients.

As co-inventor of RFA and
Osstell, looking back over two decades, what would you say about how
the technique and company have
evolved?
Osstell’s technology was developed 25 years ago, utilising RFA to
measure implant stability. Implant
stability has always been of interest
to clinicians and academics as a
means of measuring osseointegration. Osstell has reﬁned ISQ measurements into a highly accurate and
repeatable method of measuring implant stability. By continual research and development, it has developed state-of-the-art technology,
currently culminating in Osstell
Beacon. Balancing the development
of technology with a close afﬁliation
with clinicians and academics alike
ensures that Osstell’s technology remains the deﬁnitive method for
measuring and understanding implant stability.

Osstell, Sweden
www.osstell.com
Hall 2, Booth C20

WELCOME TO THE MUCOINTEGRATION ERA WITH XEAL AND TIULTRA SURFACES FROM NOBEL BIOCARE
phy have been reimagined to optimise tissue integration at every level.
Going beyond the mastery of osseointegration alone, Nobel Biocare has
entered the Mucointegration era.

Xeal: The pioneering
Mucointegration surface

Surface science is taking tissue integration solutions to the next level.
In fact, it takes tissue integration to
every level. Nobel Biocare introduces
the Xeal abutment surface and
TiUltra implant surface, derived from
decades of applied anodisation expertise. From abutment to implant
apex, surface chemistry and topogra-

Dense soft-tissue contact with an
abutment can act as a barrier to protect the underlying bone and is the
basis for long-term tissue health and
stability. Xeal is a pioneering surface
for soft-tissue integration that demonstrates a statistically signiﬁcant increase in soft-tissue height compared
with machined abutments. A smooth,
non-porous, nanostructured and anodised surface, Xeal possesses
surface chemistry and
topography that are specially designed to promote soft-tissue attachment.

TiUltra: More than
roughness
When it comes to osseointegration, treatment suc-

28 th EAO Annual Scientiﬁc Meeting

cess with implants that have a moderately rough anodised surface is
well proven. Now, Nobel Biocare’s
extensive expertise in anodisation
technology has led to the creation of
TiUltra, an ultra-hydrophilic, multizone implant surface that goes beyond roughness alone—it grasps the
power of chemistry too.
TiUltra’s precisely tailored surface chemistry is achieved by anodising the surface with a speciﬁc electrolytic solution. This solution enhances the chemical composition of
the oxide layer to positively inﬂuence
the interaction between surface and
proteins.
For ideal integration and longterm tissue stability, different tissues demand different surfaces.
To meet this need, TiUltra’s topography changes gradually
from a minimally rough, nonporous and nanostructured collar to a moderately rough and
porous apex. Fundamentally, it respects the natural transition

from hard, dense cortical bone to
spongy, porous cancellous bone to
achieve the ultimate goal of both
early osseointegration and long-term
bone stability.

Pristine surface from
production to placement
The pristine surface chemistry
and hydrophilicity of Xeal and TiUltra,
achieved with Nobel Biocare’s extensive expertise in implant surfaces,
are preserved throughout shelf life
by a protective layer, which dissolves
when in contact with any liquid,
such as blood. This layer ensures
that the quality of the implant and
abutment surfaces is maintained
from production to placement—for the ultimate beneﬁt
of the patient.

Surface science
matters
Nobel Biocare makes no
compromise in maintaining an unshakeable focus on deep science behind new solutions. Building on a
foundation of nearly two decades of

research supporting the success of anodised-surface implants, rigorous science and testing have been key driving forces behind the creation of Xeal
and TiUltra, on a fundamental mission
towards long-term treatment success.
For new Nobel Biocare solutions, it is
scientiﬁc scrutiny that really counts.
For an in-depth insight into
the evidence supporting Xeal and
TiUltra, a dedicated Clinical Implant
Dentistry and Related Research supplement provides a compelling story
covering design and in vitro characterisation, behaviour in animal studies, and most notably, the premarket
clinical study.
The Xeal surface is available
for the On1 Base and the Multiunit Abutment. TiUltra is available
on Nobel Biocare’s best-selling
NobelActive and NobelParallel Conical Connection implants.
Nobel Biocare,
Switzerland
www.nobelbiocare.com
Hall 2, Booth C15

[13] => TDI0819_01-16.pdf

industry

PIONEERING TECHNOLOGY 2019: X-MIND PRIME 3D IS THE PERFECT PROFESSIONAL SOLUTION
X-Mind prime is the latest addition to ACTEON’s CBCT digital imaging product line. It blends cutting-edge technology with ease of
use in a compact design. With X-Mind
prime 3D, high-tech is at your ﬁngertips with tools for accurate diagnosis
and complete treatment planning.
It is a lightweight and compact system that can ﬁt into any dental ofﬁce.
ACTEON is showcasing its new product at the EAO 2019.
X-Mind prime is a complete solution that combines 2D and 3D technologies. Using a single sensor, practitioners can quickly and easily
switch between modes. With these
features, X-Mind prime offers a wide
range of possible examinations,
24 options for panoramic and 32 for
CBCT, covering many clinical applications, including implantology, endodontics, and temporomandibular
joint and sinus imaging. Practitioners can also scan 3D objects such as
plaster models and silicone impressions, opening up new possibilities.
Hence, all dental practices can now
offer their patients 3D imaging and
expand their clinical applications
with this solution.
These are just a few of the possibilities that X-Mind prime offers. Furthermore, when equipped with the

ACTEON Imaging Suite precision
software, which is compatible with
both Windows and macOS operating
systems, the unit provides advanced
functionality. Intuitive image han-

ensures an accurate, reliable and
rapid treatment.
X-Mind prime is a lightweight
and compact system, and consequently, this equipment can ﬁt into

Delivered preassembled to the ofﬁce
and installed by a single specialist
technician, the unit is up and running in under an hour, not interfering with the daily workload.

dling and state-of-the-art tools simplify implant planning. In addition,
customised reports improve communication and the unique solution facilitates diagnosis. For patients, this

very small spaces. However, the ingenuity of X-Mind prime does not
end there! With its intelligent wallmounted system, the unit adapts easily to all ofﬁce space conﬁgurations.

Using X-Mind prime provides
true comfort to practitioners in their
daily practice. The unit is also remarkably easy to use: the patient is
positioned face to face with the prac-

titioner while in operation, and the
simpliﬁed control panel located under the chin support allows simple
and accurate handling. Automatic
chin support recognition, based on
the type of operation selected, allows
error-free patient positioning. This
represents signiﬁcant time-saving.
Acquiring X-Mind prime is more
than just buying a device. ACTEON
believes the quality of its customer
service is every bit as important as
the quality of its products. The group
provides personalised support based
on each practitioner’s needs and
speciﬁc situation. A pioneer in the
manufacturing of innovative and
less invasive dental imaging solutions, ACTEON is expanding its panoramic and CBCT product line with
X-Mind prime. The device is an all-inone solution that integrates 2D and
3D imaging and combines all of the
group’s high-tech expertise with its
service quality.
Attendees of EAO 2019 are invited to discover the new X-Mind
prime 3D at ACTEON’s booth.

ACTEON, France
www.acteongroup.com
Hall 1, Booth H03–H05

Join the largest educational network in dentistry!
www.DTStudyClub.com

Tribune Group GmbH is an ADA CERP Recognized Provider.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP
does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.
Tribune Group GmbH designates this activity for one continuing education credit.

28 th EAO Annual Scientiﬁc Meeting

[14] => TDI0819_01-16.pdf

travel

What’s on in Lisbon, 26 to 28 September
Belém Tower
• Where: Avenida Brasília
• Opening hours:
Tuesday–Sunday 10:00–18:30
This Lisbon landmark, built in
the sixteenth century on the northern bank of the Tagus river, served as

a fortress and ceremonial gateway to
Lisbon.
It was built during the height of
the Portuguese Renaissance and is a
prominent example of the Portuguese Manueline style but also incorporates hints of other architectural
styles. Thus, both the interior and ex-

terior of the tower offer much to explore and appreciate.
Since 1983, the tower has been a
UNESCO World Heritage Site, along
with the Jerónimos Monastery. It is
often portrayed as a symbol of Europe’s Age of Discovery and as a
metonym for Portugal or Lisbon.

© anyaivanova/Shutterstock.com

Pastel de Belém
• Where:
Pastéis de Belém,
Rua de Belém 84–92
• Opening hours:
Daily 8:00–23:00
• Information:
pasteisdebelem.pt/en/

AD

The Pastéis de Belém bakery
started to make its famous tarts of
ﬂaky pastry and custard in 1837 according to an ancient recipe from
the Jerónimos Monastery. This secret recipe has remained unchanged
ever since and is recreated every
day, by hand, using only traditional
methods. Besides the Pastel de
Belém, the bakery offers other specialities.
© Natalia Mylova/Shutterstock.com

The largest annual
world Dental Meeting!
Waiting for you in 2020!
/ciosp

_ciosp

www.ciosp.com.br
atendimento.congressista@apcdcentral.com.br

14

28 th EAO Annual Scientiﬁc Meeting

Banksy exhibition
• When: 14 June to 27 October
• Where: Cordoaria Nacional,
Avenida da Ìndia
• Opening hours: Monday–Friday
and Sunday 10:00–19:00 |
Saturday 10:00–20:00
• Information:
www.banksyexhibition.pt/en/
Cordoaria Nacional—which is in
close proximity to the Lisbon congress centre—is hosting the “Banksy:
Genius or Vandal?” exhibition, the
ﬁrst big display in Portugal of the artist who revolutionised contemporary
art and whose identity remains unknown.
The immersive exhibition features more than 70 creations, lent by
international private collectors and
galleries, and includes original
pieces, sculptures, installations, vid-

[15] => TDI0819_01-16.pdf

travel

and Technology), O’culto da Ajuda, the
Museu Nacional de Arte Antiga and
the Museu do Oriente. Entry is free.

Santa Casa
Alfama 2019 festival
• When: 27 and 28 September
• Where: Different venues in Alfama
• Information:
www.visitlisboa.com/en/events/
festival-santa-casa-alfama-19

eos and photographs of the artist displayed in different themed areas.
The experience begins with an
audiovisual presentation, speciﬁcally
created to welcome visitors to the exhibition, that reveals clues about the
mysterious artist and highlights the
most important pieces. Among the
most recognised works of the exhibition is the original serigraph of the
series Girl with Balloon.

life to be lived and inviting an exploration of the tangible and intangible
components of art and leisure.
Street performances, concerts, traditional theatre and museums, contemporary cinema and digital art are
just some of the art forms marking
this event, which will take place at a
number of venues, including the
MAAT (Museum of Art, Architecture
© BLUR LIVE 1975/Shutterstock.com

European Heritage Days 2019
• When: 27–29 September
• Where: Different venues across
the city
• Information: www.visitlisboa.com/
en/events/european-heritagedays-19
The European Heritage Days
2019 will explore the theme of arts,
heritage and leisure. The theme is intended to highlight the many facets
of heritage linked to the arts, as a
source of entertainment and leisure,
allowing other dimensions of daily

Santa Casa Alfama is a music festival that celebrates authentic and
traditional Portuguese music. For
two days, Lisbon’s eponymous district is taken over by Fado musicians
and fans of all ages. Fado means “destiny” or “fate” and is a music genre
that can be traced back to the 1820s
in Lisbon, but probably has much
earlier origins. In 2011, Fado was
added to the representative list of
Oral and Intangible Heritage of Humanity by UNESCO.

The seventh Santa Casa Alfama
festival, with ten stages and more
than 40 acts, invites music lovers to
experience the traditional sounds of
Portuguese music surrounded by the
beautiful architecture of the oldest
quarter in Lisbon.
The performances take place in a
wide variety of venues, from churches
to museums, at outdoor venues and
recreational associations, and provide visitors with a unique artistic
range of music, worthy of appreciation.

Useful information for the
city of Lisbon
• Time zone: UTC/GMT + 1 hour
• Emergency numbers: Ambulance
service/police: 112
• Currency: Euro
• Tourist information: Rua do Arsenal
15 (Monday–Friday 9:30–19:00)
• Foreign ministry: Portuguese Ministry of Foreign Affairs: www.portaldiplomatico.mne.gov.pt/en/

• Credit card acceptance: Credit
cards like Mastercard and Visa are
widely accepted throughout Portugal. However, it is advisable to
carry some cash, as some restaurants or shops accept only cash or
set a minimum purchase value of
€ 10 for credit card payments.

Additional information for the
EAO congress
• Congress app:
The congress registration fee includes the free download and use of
the congress app. EAO attendees can
use this app to view the programme,
look at individual sessions and
browse abstracts. At the end of the
congress, participants can send themselves an individual visit report, including personal notes and bookmarks. Over the years, the app has become an essential tool for exclusive
scientiﬁc content, promoting the congress’s aim of becoming paperless in
the near future.
AD

28 th EAO Annual Scientiﬁc Meeting

[16] => TDI0819_01-16.pdf

Visit us at
booth C15

Surface chemistry cells can’t resist.
Introducing Xeal and TiUltra – two new breakthrough surfaces derived from our decades
of applied anodization expertise. From abutment to implant apex, we have reimagined
surface chemistry and topography to optimize tissue integration at every level.
We’ve now entered the Mucointegration™ era.

The new Xeal surface is now
available for the On1™ Base
and the Multi-unit Abutment.
TiUltra is available on our best
selling NobelActive® and
NobelParallel™ CC implants.

) [page_count] => 16 [pdf_ping_data] => Array ( [page_count] => 16 [format] => PDF [width] => 794 [height] => 1134 [colorspace] => COLORSPACE_UNDEFINED ) [linked_companies] => Array ( [ids] => Array ( ) ) [cover_url] => [cover_three] =>

[cover] => today EAO Lisbon 26 September 2019

[toc] => Array ( [0] => Array ( [title] => EAO 2019 builds bridges to future of implantology [page] => 01 ) [1] => Array ( [title] => News [page] => 02 ) [2] => Array ( [title] => Floor plan [page] => 08 ) [3] => Array ( [title] => List of exhibitors [page] => 09 ) [4] => Array ( [title] => Industry [page] => 10 ) [5] => Array ( [title] => Travel [page] => 14 ) ) [toc_html] =>

Table of contents

[toc_titles] =>

EAO 2019 builds bridges to future of implantology / News / Floor plan / List of exhibitors / Industry / Travel

[cached] => true )